Wikisage, the free encyclopedia of the second generation, is digital heritage
Levetiracetam: Difference between revisions
Jump to navigation
Jump to search
(→ATC: n03) |
(→ATC) |
||
Line 20: | Line 20: | ||
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501738/ A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache] | *[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501738/ A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache] | ||
[[File:Wikidata-logo-en.svg.png|32px]][https://www.wikidata.org/wiki/Q417227 Q417227] | [[File:Wikidata-logo-en.svg.png|32px]][https://www.wikidata.org/wiki/Q417227 Q417227] | ||
<references/< | |||
[[Category:Anticonvulsants]] | [[Category:Anticonvulsants]] |
Revision as of 03:19, 6 October 2015
(S)-2-(2-Oxopyrrolidin-1-yl)butanamide is an anticonvulsant medication used to treat epilepsy. It is the S-enantiomer of etiracetam, structurally similar to the prototypical nootropic drug piracetam.
Extended release
Links
ATC
Trinka E., et al 2015
- Pharmacotherapy for Status Epilepticus Drugs 75:1499
Safraski J.-P.2015
Jackson J.-L. et al.2015
<references/<